Skip to main content

Antibiotic Limits Planned for Farms

The Food and Drug Administration lays out a plan so that farmers will no longer use antibiotics to fatten up animals.  

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, RYAN THOMPSON/US DEPARTMENT OF AGRICULTUREIn an effort to slow the problem of antibiotic resistance, the US Food and Drug Administration (FDA) announced new rules for farmers. No longer will farmers be able to give animals antibiotics to make livestock or poultry grow bigger. And if an antibiotic is needed to treat a sick animal, farmers will have to get a prescription from a veterinarian.

“With these changes, there will be fewer approved uses, and the remaining uses will be under tighter control,” Michael Taylor, deputy commissioner for foods and veterinary medicine at the FDA, told CNN.

The plan hinges on pharmaceutical companies complying with a request to change the labeling on their products. Drugmakers are asked to remove language from the labeling of antibiotics touting their growth-promoting qualities, but are not required to do so. “Once manufacturers voluntarily make these changes, the affected products can then only be used in food-producing animals to treat, prevent, or control disease under the order of or by prescription from a licensed veterinarian,” according to the FDA.

Some, including the American Meat Institute and the Animal Health Institute, support the move. Clinton Lewis, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays